当前位置:首页 - 行情中心 - 金城医药(300233) - 财务分析 - 资产负债表

金城医药

(300233)

  

流通市值:42.44亿  总市值:43.76亿
流通股本:3.72亿   总股本:3.84亿

资产负债表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
流动资产:
  货币资金782,614,133.99963,334,464.55776,238,222.72825,798,100.6
  交易性金融资产160,000,000-180,000,00070,000,000
  衍生金融资产---20,987.16
  应收票据及应收账款407,673,345.04457,477,427.75567,993,779.28566,278,606.95
  其中:应收票据--23,910,206.4931,392,062.71
        应收账款407,673,345.04457,477,427.75544,083,572.79534,886,544.24
  应收款项融资217,943,382.71208,454,880.69165,655,892.1125,520,101.18
  预付款项29,645,131.3823,282,482.9328,272,985.6623,930,814.33
  其他应收款合计3,856,450.43,886,076.193,680,311.793,472,578.54
  存货489,447,073.38486,589,979.21446,540,224.09464,607,381.98
  其他流动资产15,398,94326,310,276.996,374,111.676,205,853.56
  流动资产合计2,106,578,459.92,169,335,588.312,174,755,527.312,085,834,424.3
非流动资产:
  长期股权投资18,200,939.6418,266,325.7118,328,931.2918,400,459.4
  其他权益工具投资168,441,261.6162,441,261.6163,441,261.6163,441,261.6
  固定资产1,976,173,473.092,020,847,036.952,079,085,828.652,137,608,115.56
  在建工程29,626,019.5416,466,671.448,994,262.353,362,026.35
  使用权资产3,638,062.876,069,277.66,597,663.287,126,048.96
  无形资产537,904,908.23547,178,228.31542,975,551.52545,609,701.21
  开发支出86,316,673.6194,561,206.08132,320,264.09138,861,588.64
  长期待摊费用6,990,893.437,774,412.698,557,931.929,119,615.18
  递延所得税资产31,349,262.9137,409,842.9441,866,968.9147,602,189.36
  其他非流动资产33,952,670.528,523,284.4934,042,027.0633,926,241.52
  非流动资产合计2,892,594,165.422,939,537,547.813,036,210,690.673,105,057,247.78
  资产总计4,999,172,625.325,108,873,136.125,210,966,217.985,190,891,672.08
流动负债:
  短期借款95,045,130.5680,045,482.2370,045,130.55120,076,880.56
  衍生金融负债76,013.396,260.06128,103.96-
  应付票据及应付账款439,942,816.37421,140,974.38469,580,668.17498,187,495.69
  其中:应付票据150,518,772.45110,812,224155,280,241.63154,154,513.42
        应付账款289,424,043.92310,328,750.38314,300,426.54344,032,982.27
  预收款项132,139.53100,149.89--
  合同负债39,170,395.2337,712,662.95107,514,448.4640,779,189.04
  应付职工薪酬196,947,976.79180,328,446.88157,690,426.3185,543,719.97
  应交税费23,604,256.0327,990,583.3441,497,965.7334,569,111.05
  其他应付款合计131,297,794.34150,369,316.52159,602,373.43170,694,612.62
  一年内到期的非流动负债103,007,843.05235,555,891.14244,791,292.54170,436,860.19
  其他流动负债2,630,650.583,371,358.334,267,695.781,801,067.26
  流动负债合计1,031,855,015.781,136,711,125.721,255,118,104.921,222,088,936.38
非流动负债:
  长期借款16,471,259.0316,970,730.1417,477,78085,522,784.31
  租赁负债324,934.172,386,072.44,061,461.853,400,065.08
  预计负债98,192.7669,300--
  递延收益38,623,226.3340,854,700.2543,187,776.145,235,415.9
  递延所得税负债97,364,025.14102,249,088.68106,803,934.12110,678,705.01
  非流动负债合计152,881,637.43162,529,891.47171,530,952.07244,836,970.3
  负债合计1,184,736,653.211,299,241,017.191,426,649,056.991,466,925,906.68
所有者权益(或股东权益):
  实收资本(或股本)383,874,587383,874,587383,874,587383,874,587
  资本公积2,330,377,337.992,330,377,334.252,330,377,334.252,330,377,334.25
  减:库存股55,009,17055,009,17055,009,17055,009,170
  其他综合收益50,900,262.8750,900,262.8751,650,262.8751,650,262.87
  专项储备10,967,569.1910,935,951.5710,453,578.769,112,422.52
  盈余公积165,120,502.47165,120,502.47165,120,502.47165,120,502.47
  未分配利润865,896,502.68860,233,437.54836,054,180.15778,259,677.39
  归属于母公司股东权益合计3,752,127,592.23,746,432,905.73,722,521,275.53,663,385,616.5
  少数股东权益62,308,379.9163,199,213.2361,795,885.4960,580,148.9
  股东权益合计3,814,435,972.113,809,632,118.933,784,317,160.993,723,965,765.4
  负债和股东权益合计4,999,172,625.325,108,873,136.125,210,966,217.985,190,891,672.08
公告日期2026-10-292026-08-212026-04-242026-03-27
审计意见(境内)标准无保留意见
TOP↑